These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 10554569

  • 1. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J, Soszyński P.
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [Abstract] [Full Text] [Related]

  • 2. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 3. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Nov; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A, Willms B.
    Med Klin (Munich); 1994 Apr 15; 89(4):187-92. PubMed ID: 8015532
    [Abstract] [Full Text] [Related]

  • 5. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M, Mujica V, Muñoz S, Durruty P, Larenas G, López MI, Kuzmanic A, Pérez J, Flaskamp R, Cumsille F.
    Rev Med Chil; 1997 Aug 15; 125(8):856-62. PubMed ID: 9580485
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of acarbose as monotherapy in NIDDM patients.
    Deerochanawong C, Serirat S, Kornthong P.
    J Med Assoc Thai; 1996 Feb 15; 79(2):69-75. PubMed ID: 8868016
    [Abstract] [Full Text] [Related]

  • 7. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.
    Ogawa S, Takeuchi K, Ito S.
    Diabetes Obes Metab; 2004 Sep 15; 6(5):384-90. PubMed ID: 15287932
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 15; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ.
    Diabetes Metab; 1998 Sep 15; 24(4):311-20. PubMed ID: 9805641
    [Abstract] [Full Text] [Related]

  • 10. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
    Aubell R, Boehme K, Berchtold P.
    Arzneimittelforschung; 1983 Sep 15; 33(9):1314-8. PubMed ID: 6357206
    [Abstract] [Full Text] [Related]

  • 11. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 15; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep 15; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 13. Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes.
    Pistrosch F, Schaper F, Passauer J, Koehler C, Bornstein SR, Hanefeld M.
    Horm Metab Res; 2009 Feb 15; 41(2):104-8. PubMed ID: 19061152
    [Abstract] [Full Text] [Related]

  • 14. International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus.
    Li C, Hung YJ, Qamruddin K, Aziz MF, Stein H, Schmidt B.
    Diabetes Res Clin Pract; 2011 Apr 15; 92(1):57-64. PubMed ID: 21251726
    [Abstract] [Full Text] [Related]

  • 15. Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study.
    Hanefeld M, Schaper F, Koehler C, Bergmann S, Ugocsai P, Stelzer J, Schmitz G.
    Horm Metab Res; 2009 Feb 15; 41(2):132-6. PubMed ID: 19214923
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of acarbose in type 2 diabetes mellitus in Jamaica.
    Morrison EY, Wright-Pascoe R, Aquart A, Robinson H, Banbury M, Whitbourne F, Callender J, Less L, Bailey S.
    West Indian Med J; 2000 Dec 15; 49(4):285-9. PubMed ID: 11211536
    [Abstract] [Full Text] [Related]

  • 17. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N, Burkert A, Haak T.
    Exp Clin Endocrinol Diabetes; 2004 Jun 15; 112(6):310-4. PubMed ID: 15216448
    [Abstract] [Full Text] [Related]

  • 18. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun 15; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

  • 19. [Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].
    Heuer LJ, Kaufmann HH.
    Dtsch Z Verdau Stoffwechselkr; 1985 Jun 15; 45(2):52-8. PubMed ID: 3924553
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J, Czupryniak L.
    Med Sci Monit; 2003 Jun 15; 9(6):CR240-3. PubMed ID: 12824953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.